Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | N/A | N/A | N/A | N/A | 4,648 |
| Gross Profit | N/A | N/A | N/A | N/A | 4,648 |
| Operating Expenses | 12,653 | 12,361 | 9,478 | 8,252 | 9,447 |
| Operating Income | -12,653 | -12,361 | -9,478 | -8,252 | -4,798 |
| Interest Expense | N/A | N/A | N/A | 6 | 2 |
| Other Income | 4,337 | 1,024 | 4,288 | 3,517 | -191 |
| Pre-tax Income | -8,316 | -11,337 | -5,190 | -4,741 | -4,991 |
| Net Income Continuous | -8,316 | -11,337 | -5,190 | -4,741 | -4,991 |
| Minority Interests | 19 | 38 | 97 | 91 | 97 |
| Net Income | $-8,297 | $-11,299 | $-5,094 | $-4,650 | $-4,893 |
| EPS Basic Total Ops | -0.11 | -0.18 | -0.09 | -0.12 | -0.23 |
| EPS Basic Continuous Ops | -0.11 | -0.18 | -0.09 | -0.12 | -0.23 |
| EPS Diluted Total Ops | -0.11 | -0.18 | -0.09 | -0.12 | -0.23 |
| EPS Diluted Continuous Ops | -0.11 | -0.18 | -0.09 | -0.12 | -0.23 |
| EBITDA(a) | $-12,553 | $-11,932 | $-9,117 | $-4,381 | $-4,587 |